Home pageOPL • ASX
add
Opyl Ltd
Chiusura precedente
0,019 $
Intervallo annuale
0,014 $ - 0,033 $
Cap di mercato
2,75 Mln AUD
Volume medio
110.333,00
Rapporto P/E
-
Dividendo/Prezzo
-
Borsa valori principale
ASX
Notizie del mercato finanziario
Dati finanziari
Conto economico
Entrate
Utile netto
| (AUD) | dic 2024info | Variazione Y/Y |
|---|---|---|
Entrate | 167.721,00 | 37,65% |
Spese di gestione | 323.383,00 | 42,41% |
Utile netto | -341.596,00 | 46,47% |
Margine di profitto netto | -203,67 | 61,11% |
Utili per azione | — | — |
EBITDA | -318.039,00 | 25,38% |
Aliquota fiscale effettiva | — | — |
Stato patrimoniale
Totale attivo
Totale passivo
| (AUD) | dic 2024info | Variazione Y/Y |
|---|---|---|
Investimenti cash/breve termine | 329.547,00 | -43,64% |
Totale attivo | 384.824,00 | -41,63% |
Totale passivo | 695.816,00 | -3,76% |
Patrimonio netto totale | -310.992,00 | — |
Azioni in circolazione | 170,80 Mln | — |
Prezzo/valore contabile | ∞ | — |
Redditività dell'attivo | -208,46% | — |
Rendimento sul capitale | -683,20% | — |
Flusso di cassa
Flusso di cassa netto
| (AUD) | dic 2024info | Variazione Y/Y |
|---|---|---|
Utile netto | -341.596,00 | 46,47% |
Liquidità di esercizio | -309.990,00 | -6,88% |
Contanti da investimenti | -662,00 | — |
Contanti da finanziamenti | 288.103,00 | -19,06% |
Flusso di cassa netto | -22.549,00 | -134,21% |
Flusso di cassa libero | -200.744,00 | 18,01% |
Informazioni
Opyl is a Melbourne-based company listed on the Australian Securities Exchange that applies artificial intelligence to improving clinical trial efficiencies. The company has two key platforms: Opin a global clinical trial recruitment platform and service as well as TrialKey a Saas software as a service platform that predicts and designs optimized clinical trial protocols, reducing the risk of failure and improving a return on investment in new and emerging medicines, devices, and diagnostics..
Opyl is a rebrand and strategic realignment from a former company known as ShareRoot, a US-based martech platform that secured rights to user-generated content on social media, predominantly used by big brands that collaborated with influencers.
Before going public in 2016, ShareRoot had previously participated in 500 Startups batch 8 and raised a round of angel investing.
ShareRoot was rebranded to Opyl in 2020 to work on technology to support the health and life sciences sector. Wikipedia
Fondazione
2013
Sito web
Dipendenti
3
